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former preferentially synthesizes GABA for vesicular release, the latter 
for cytoplasmic stores (Soghomonian and Martin, 1998). Indeed, ratio 
of GAD65 to GAD67 is higher in synaptic vesicle fractions than in cytosol 
(Solimena et al., 1993). GAD65 may be anchored to synaptic vesicles 
by forming a complex that includes the vesicular GABA transporter 
VGAT, an integral membrane protein of synaptic vesicles responsible 
for their filling (McIntire et al., 1997). This may provide a structural 
and functional coupling between synthesis and vesicular packaging of 
GABA (Hsu et al., 2000; Jin et al., 2003). Interestingly, [3H]GABA newly 
synthesized from [3H]Glu by synaptic vesicle-associated GAD is taken 
up preferentially into vesicles over cytosolic GABA (Jin et al., 2003). 
Minor sources of GABA, such as putrescine, spermine, spermidine, and 
ornithine, offer a negligible contribution to releasable GABA.
Glu used for GABA synthesis may originate from diverse sources.
Glu–GABA/glutamine cycle
Glutamate derived from glutamine (Gln) is an important GABA pre-
cursor (Bradford et al., 1983; Sonnewald et al., 1993). Released GABA 
is taken up by astrocytic transporters (i.e., GAT-3; Minelli et al., 1996), 
and catabolized to the tricarboxylic acid (TCA) cycle intermediate 
succinate by GABA transaminase and succinate semialdehyde dehy-
drogenase; the resulting α-ketoglutarate is then transformed to Glu 
which is converted to Gln by Gln synthetase (Martinez-Hernandez 
et al., 1977). Gln is then extruded from astrocytes by SNAT3, a system 
N transporter (Chaudry et al., 1999, 2002; Boulland et al., 2002), 
and taken up by axon terminals. Gln influx into neurons is thought 
to be mediated by SNAT1 and/or SNAT2, two system A transport-
ers (Fricke et al., 2007); this view is compatible with expression of 
SNAT1 and SNAT2 in most GABAergic cells (Melone et al., 2004, 
2006; Conti and Melone, 2006). In neurons, Gln is converted to Glu 
by phosphate-activated glutaminase (PAG; Kvamme et al., 2001). 
INTRODUCTION
In his Nobel Lecture, given on December 12, 1970, Julius Axelrod 
summarizes his seminal work on noradrenaline (NET) metabolism 
and uptake. In the paragraph entitled Effect of drugs on neuronal 
uptake he describes how blocking NET uptake using cocaine or other 
drugs resulted in a dramatic decrease in tissue [3H] NET and addresses 
the question of whether, in addition to blocking uptake, “these drugs 
could prevent storage or release of [3H] NET” (Axelrod, 1971). Ever 
since, the possible role of transport mechanisms on transmitter stor-
age and release of neurotransmitters has been essentially neglected. 
Advent of molecular cloning and knock-out technologies made it 
possible to unveil the nature of proteins mediating neurotransmit-
ter transport (transporters) and to investigate their functional role 
in vivo. Mice lacking dopamine (DAT), NET, or serotonin (SERT) 
transporters exhibit an increase of extracellular lifetime and levels 
of monoamines and a decrease of both their intracellular storage 
and release (Torres et al., 2003). These findings indicate that, besides 
terminating synaptic transmission by clearing released transmitters, 
monoamine  transporters  mediate  replenishment  of  transmitter 
stores, thus regulating presynaptic homeostasis. Here, we analyze 
whether the same principle applies to GABAergic synapses1.
GABA SYNTHESIS AND TRANSPORT: A COMPLEX SCENARIO
GABA SYNTHESIS
Most GABA is synthesized from glutamate (Glu) by glutamic acid 
decarboxylase (GAD; Roberts and Frankel, 1950, 1951). In mammalian 
brain, GAD occurs in two molecular forms, GAD65 and GAD67; the 
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doi: 10.3389/fncel.2011.00002PAG immunoreactivity (ir) is detected in ∼18% of all puncta express-
ing VGAT, which is expressed in all GABAergic terminals (Chaudhry 
et al., 1998; Minelli et al., 2003), and electron microscope studies show 
that ∼20% of all PAG+ axon terminals making synaptic contacts form 
symmetric synapses (Figures 1A,B).
TCA cycle
Glutamate is synthesized in all cells from intermediates in the TCA 
cycle, and neurons are capable of de novo synthesis of Glu from TCA 
cycle intermediates, indicating that neuronal TCA cycle contribute 
significantly to Glu synthesis (Peng et al., 1993).
Glu transporters
Glutamate used for GABA synthesis could derive from the action of 
Glu transporters (GluT). EAAC1 is a neuronal GluT expressed also 
by GABAergic neurons (Rothstein et al., 1994; Conti et al., 1998a): 
in hippocampal slices from EAAC1 antisense-treated animals incu-
bated in the presence of DON and gabaculine, newly synthesized 
[14C]GABA from [U–14C]Glu is lower in the presence of the Glu 
transport inhibitor DL-threo-β-hydroxy-aspartic acid; moreover, 
patch-clamp recordings of miniature IPSCs (mIPSCs) conducted 
in CA1 pyramidal neurons demonstrated a significant decrease in 
mIPSC amplitude, indicating decreased tonic inhibition (Sepkuty 
et al., 2002; see also Mathews and Diamond, 2003; Hartmann et al., 
2008). The possible contribution of other GluTs (e.g., EAAT4 and 
GLT-1) to GABA synthesis remains to be verified.
GABA TRANSPORT
Four GABA transporters have been identified: GAT-1, GAT-2, GAT-
3, and BGT-1 (Borden, 1996). GAT-1 is localized almost exclusively 
to axon terminals forming symmetric synaptic contacts and, in neo-
cortex, to some astrocytic processes (Minelli et al., 1995; Conti et al., 
1998b); GAT-2 is mainly expressed in the leptomeninges and in 
ependymal and choroid plexus cells, and to a lesser extent in neu-
rons and astrocytes (Conti et al., 1999); GAT-3 is exclusively local-
ized to distal astrocytic processes (Minelli et al., 1996); and BGT-1 
is not localized to the CNS (Borden, 1996; Cherubini and Conti, 
2001; Conti et al., 2004). Thus, the only GABA transporter that can 
contribute directly to GABA replenishment in terminals is GAT-1.
ARE MECHANISMS SUBSERvING GABA SYNTHESIS AND TRANSPORT 
EXPRESSED IN ALL GABAERGIC TERMINALS?
Crucial to the theme raised in this Perspective is whether the two 
mechanisms for GABA replenishment (synthesis and transport) 
are segregated in different terminals. Recent co-localization studies 
show that both GADs and GAT-1 are expressed in 90% of VGAT+ 
terminals (Figure 1B). Considering technical limitations, these val-
ues indicate that virtually all GABAergic terminals express both 
GADs and GAT-1 – i.e., that virtually all GABAergic neurons can 
synthesize GABA and take it up from extracellular milieu – and 
that GABAergic terminals cannot be differentiated on the basis of 
their mechanism of GABA replenishment.
INSIGHTS FROM KO MICE
GAT-1 deficient mice exhibit normal reproduction and life span, 
but have reduced body weight and higher body temperature fluc-
tuations; they display motor disorders, including gait abnormality, 
25–32 Hz tremor, reduced rotarod performance, and locomotor 
activity; they also display mild anxiety or nervousness (Jensen et al., 
2003; Chiu et al., 2005).
In CA1 pyramidal cells, cerebellar granule and Purkinje cells, 
and neocortical layer II/III pyramids of KO mice, GABAA recep-
tors (R)-mediated tonic conductance is significantly increased. 
Frequency,  amplitude,  and  kinetics  of  spontaneous  IPSCs  are 
unchanged, whereas the decay time of evoked IPSCs is prolonged 
in KO mice (Jensen et al., 2003; Chiu et al., 2005; Bragina et al., 
2008). In neocortex, high-frequency stimulation of GABAergic 
terminals induces large GABAAR-mediated inward currents asso-
ciated with a reduction in amplitude and decay time of IPSCs; the 
recovery process is slower in KO than in WT mice (Bragina et al., 
2008). Thus, GAT-1 has a prominent role in both tonic and phasic 
GABAAR-mediated inhibition, in particular during sustained neu-
ronal activity (Bragina et al., 2008). The effects reported in KO mice 
are ascribable to impaired GABA uptake and subsequent reduction 
of GABA clearance from the synaptic cleft, a conclusion that would 
rule out any significant role of GAT-1 on presynaptic homeostasis.
However, analysis of mIPSCs in hippocampal pyramidal cells 
recorded  in  the  presence  of  tetrodotoxin  show  that  whereas 
  mIPSCs  have  similar  rise  times,  decay  time  constants,  and 
FIGure 1 | Anatomical insight into GABAergic presynaptic terminals. (A) 
Electron microscope studies of PAG immunoreactivity. Both axon terminals 
forming asymmetric (arrows) and symmetric synapses (arrowheads) contain 
PAG-ir. Layer II–III; parietal cortex. Rat brains perfused and post-fixed for 48 h 
with 1% PFA and antiproteolytic cocktail (Melone et al., 2006); vibratome 
sections processed with mouse anti-PAG primary antibodies (1:250; Kaneko 
et al., 1987) and avidin–biotin. Quantitative data from two animals. (B) 
Co-localization studies of VGAT/PAG (left), VGAT/GADs (middle), and VGAT/
GAT-1 (right). In all series, green codes for VGAT. VGAT/PAG series: tissue 
preparation as in A; anti-VGAT antibodies (1:500; Synaptic System; No. 
131003); anti-PAG antibodies (1:250; Kaneko et al., 1987). VGAT/GADs series: 
tissue perfused and post-fixed for 24 h with 4% PFA; anti-VGAT antibodies 
(1:50; Synaptic System; No. 131011); anti-GAD65/67 antibodies (1:800; 
Millipore; AB1511). VGAT/GAT-1 series: tissue perfused and post-fixed for 2 h 
with 4% PFA; anti-VGAT antibodies (1:50; Synaptic System; No. 131011); 
anti-GAT-1 antibodies (1:500; Minelli et al., 1995). For studies employing PAG 
antibodies, fixative conditions were selected on the basis of the results of 
preliminary studies performed to ascertain optimal conditions. Layer II–III; 
parietal cortex. Percentage of VGAT puncta co-localized with PAG, GADs, and 
GAT-1 defined by analysis of 60–80 microscopic cortical fields (from layers  
I–VI) from two animals for each antigen. Scale bars: 0.25 μm (upper row) and 
5 μm (lower row).
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CONCLUSION
In monoamine-releasing terminals, neurotransmitter transporters 
are crucial for presynaptic homeostasis, and this notion prompted 
us to verify whether GAT-1 plays a similar role in GABAergic termi-
nals. Re-examination of existing literature from this perspective and 
some recent data gathered in our laboratory permits some initial 
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an impaired presynaptic function; (3) notwithstanding the paucity 
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  amplitudes in WT and GAT-1 KO, their frequency in GAT-1 KO 
animals is reduced to about one-third of that recorded in control 
animals (Jensen et al., 2003; Figure 2A). Since reduced frequency of 
miniature events reflects presynaptic changes of quantal transmis-
sion (del Castillo and Katz, 1954; Clements, 1993), these findings 
indicate that in GAT-1 KO mice a presynaptic deficit does exist. 
Interestingly, simultaneous application of the GAT-1 inhibitor 
NNC-711 and of TBOA reduces mIPSC amplitudes, whereas high-
frequency stimulation of CA1 afferents determines an activity-
dependent increase in mIPSCs quantal size, that is produced by 
GAT-1-mediated GABA uptake and EAAC1-mediated Glu uptake 
in terminals of inhibitory interneurons (Hartmann et al., 2008).
Moreover, western blotting studies from neocortex of WT and 
GAT-1 KO mice show that whereas VGAT levels are unchanged, 
GAD65/67 and PAG levels are increased by 35% and 18%, respec-
tively,  in  GAT-1  KOs  compared  to WTs  (Bragina  et  al.,  2008; 
Figure  2B).  These  studies  show  that  in  conditions  in  which 
FIGure 2 | GAT-1 may contribute to presynaptic GABA storage and 
release. (A) mIPSC inter-event intervals (left) and amplitudes (right) in WT and 
GAT-1 KO hippocampal neurons. Note the longer inter-event intervals for GAT-1 
KO mIPSCs compared to WT (p < 0.01; From Jensen et al., 2003). (B) Western 
blotting studies on cortical cellular extracts show increased expression of 
GAD65/67 and PAG, but not VGAT, in GAT-1 KO mice. Age of all animals was 
comparable. VGAT and GAD65/67 data from Bragina et al. (2008). For PAG 
analysis, homogenates (10 μg/μl) were exposed to anti-PAG antibodies 
(1:1000; Akiyama et al., 1990).
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